Notice names this product. Bell Pharmaceuticals’s Clinere is named in FDA Class II recall D-0679-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). Identifying details: Lot: a) 1504241, exp 2027-03; b) 1504291, 1504301, exp 2027-03.. Units affected: 29, 474 units. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl. oz. (15 mL); b) 1 bottle of Clinere Carbamide Peroxide (0,50 fl. oz. (15 mL), Dist. by: Quest Products LLC, Pleasant Prairie, WI 53158, NDC 68229-102-01.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: Clinere recall status
Official ID D-0679-2026 · Official record ↗
See all Bell Pharmaceuticals recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 6:00 PM UTC.